Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
bag, We've been over this before.
I challenge anyone to find a company, a penny stock company, who has responded to the economic forces raging against its success as well as DNAP has.
I challenge you to provide any evidence of the "economic forces raging against it's success".
Until you can produce such clarification, no one can perform the search that is required to answer your challenge.
Is it a real challenge, or just empty rhetoric?
retro, I don't know.
If you have access to the napheads board, you could ask mingwan0. He was involved in the pp and he posts over there occasionally.
regards,
frog
bag,
-Don't mention it.
-Parody bag, parody.
-See above. Everybody believes in that vision bag, even the people that Frudakis heard it from.
- He hasn't!
regards,
frog
Dr. Frudaky,
If it is possible, for two such talented manipulators, to devalue the investments of the faithful longs to the tune of several million dollars, why hasn't anyone offered us some renumeration to cease our efforts?
Wouldn't it be cheaper to buy us off, than to call us names and provoke us?
Doesn't make sense to accuse someone of injuring your investment and then goading him on with inflamatory remarks and insults. If you think he's the sole reason for your losses, why would you engage him negatively?
What are their motives? If they actually believe their conspiratorial fantasies they would do whatever it took to tone down the flames, instead of throwing gasoline on them.
Perhaps they have hidden agendas of their own.......I wonder.....Why are they here?
regards,
frog
Bag,
It's been awhile. Welcome back. Hope all is well.
frog
gunnabe, If you are going to be crystal clear, then you need to be equally staightforward.
I confirmed that management does not have enough shares on their own to guarantee a win, IF all the O/S shares are voted. That is totally different from what you turned it into. (And you know it.)
as frog has confirmed, say that management ownership alone is NOT enough to guarantee the outcome of the vote.
That's nonsense.
There are many ways management can control the outcome of a vote by voting their shares, it depends upon the conditions and constraints set up for the vote. Remember that they are the ones that control the conditions.
As has been reiterated here, numerous times. The outcome is guaranteed. The R/S WILL be approved.
regards,
frog
Gunnabe,
If you are asking me to confirm that 13% of the share ownership is less than half, then I will do so gladly. Is that what you want?
I have never said otherwise. If all 1 Billion outstanding shares are voted then the 13% controlled by management will not be enough to guarantee the outcome.
Happy?
frog
Blue, The only thing I have a definite opinion on is the R/S. I am indifferent to the rest. The board membership, the Auditors, are fine with me.
regards,
frog
I vote No!
gunnabe,
The deal WILL be approved. You can call it a fact, not a fact, an opinion, a guess, a shot in the dark, whatever you want, but it WILL be approved.
I don't care what you call it. I will however, offer a money back guarantee. LOL
regards,
frog
Isn't this an example of a personal attack?
gunnabe, You can call it anything you like.
The milestones all require money. Regardless of how many shares are registered and how much money is 'available' from Dutchess, in order to convert shares of a company into dollars, the company HAS TO be worth at least as much as the money provided.
This means that until DNAP gets to be worth more than a few million dollars in capitalized value, the $35 Million dollar value touted from Dutchess is nonsense.
If they diluted the present shareholders slice of the company down to absolute zero, and then sold the ENTIRE company to Dutchess via share acquisition, they would realize less than $15 million. Not nearly enough to complete the 'plan'.
I repeat, the Beth Israel deal is vague.
regards,
frog
gunnabe, They have more than enough.
For the deal to be voted down, more votes have to be cast 'against' than are cast 'for'.
The clear consensus of the boards is that the faithful will vote 'for'. The management will vote 'for'. Every one of the Millions of shares sold since May 2 will be ineligible.
A very LARGE percentage of proxies WILL NOT get to the shareholders in time to be voted. The last vote was a disaster in such terms.
There is NO WAY that this deal will not be approved. Anyone who thinks that management does not have this thing already in the bag is fooling themselves.
regards,
frog
Ann, LOL
Please explain then, the status of the Biofrontera promise and the GMED promise. If I have erred in characterizing them as 'discarded' then perhaps you would enlighten us.
In regards to vague new directions, I am refering specifically to the Beth Israel deal. It has been suggested that 'sometime' in the future DNAP will develop and distribute a new version of an existing drug that has been started by Beth Israel. Given the lack of details involved and the complete lack of necessary financing, the direction can only be describes as vague, and that is giving it the benefit of the doubt.
I look forward to your response.
regards,
frog
But uncx, There is no business plan!
Business plans include such criteria as schedules, risks, forecasts, estimates of market share, budgets, Return on investment estimates (ROI), break-even timelines, etc.
If you can point anyone to such a document, it would be
appreciated.
All we have are vague new directions amid a number of discarded old promises.
regards,
frog
I would be willing to bet it is.
Standard Operating Procedure.
OT: Miss Scarlet, not just a bunch, but also a lie!........SOP?
Ann441j, I am not going to play that game my dear, Sorry.
I am not going to be responsible for dredging up old PR's and newsletters, simply because my memory is better than yours or you were not around here during those days.
I am also not interested in providing a 'defense' of everything I say, just because you or George or someone else doesn't like it.
I am not in the business of trying to change your mind or your inclination and frankly I am not in the least bit concerned about your opinion, and so I have very little incentive to do your homework for you.
If YOU wish to challenge the statement, then feel free to do so, but realize that you will need to provide some authentication yourself.
There are enough 'old timers' around here, who remember the claims from back then, to point you in the right direction, if you are really interested and not just playing games.
regards,
frog
geob,
OK 5yrs, I can understand your impatience. But honestly how long should it take?
I'm not impatient, it should take as long as it takes.
However the initial run to 50 cents all those many years ago was fueled by Frudakis promises that once the company completed the platform, classifiers would emerge at a rate of one every six months.
Today, according to the latest from management, we are still two years away.
I have said before that losing ground at a rate of 18 months for every five years invested, is no way to build investor confidence.
One would think that there would be a periodic mention of progress or milestone reached, in such an effort. Even an explanation of the unseen obstacles encountered would be appreciated, don't you think?
regards,
frog
geob, Of course.
It appears that it will up the average,
don't you think Frog?
LOL You don't have to be a 'nuclear psychiatrist' to figure that out.
When (and if) the product is used, it WILL up the average.
However, according to Gabriel, Ovanome does not yet meet it's design requirements and is not yet ready for the FDA. (One presumes that the 95% value is a design requirement, since it has been the presented benchmark since the product was announced, five years ago.)
regards,
frog
geob, Poor comparison.
Similar to a comparison between an electron microscope, that can discern the individual molecules in the center of an apple, and costs a million dollars to a two dollar magnifying glass that can see tho whole damn thing at once.
The analysis of individual SNP's on specific disease genes is not the same as investigating a few SNP's that mark individual blocks, containing millions of genes each, in a 'pan genome' screen.
regards,
frog
gunnabe,
You can build what case you like about my lack of the 'imo' convention. You can even play games regarding the imaginary requirements of such BS to qualify a FACT. A brief survey of my posts will reveal that I have never used such silliness. The only one of those 'excuses for communication' that I use with any frequency at all is 'LOL'. Permit me to present it now. LOL
regards,
frog
gunnabe,
I don't know if he posts HERE.
He does post on RB under several different aliases.
Including 'money_looser', 'sanaad', and 'stockpimpdaddy'.
The evidence has been presented several times, it is fairly comprehensive.
You demand proof. Isn't it funny how "Proof" is required for any claims that run counter to the your worldview, but nothing is required to support a claim that coincides with it?
Given the nature of anonymous aliases and the illegal nature of the participation, the evidence will NEVER stand up in, say, a court of law. However, for the discerning individual the case is more than adequate to provide a high level of confidence. More than enough to realize the complicity of the individual and to be wary of his intentions.
regards,
frog
So....No denial, OK.
As to suggesting I read the Option Agreement, I love it.
I remember going back and forth with you years ago about it. You claiming that the end of the time span was imminent based on your interpretation, and me suggesting that DNAP had nothing to offer that would even start the clock, until they had a marketable product or a patent.
Your condescending dismissal of any dissention was hilarious. For you now to offer my own position back and claim it as your own is hysterical.
Hurry back, we are desperately in need of the comic relief.
regards,
frog
worktoplay, How nice of you to visit.
Do you deny 'reading between the lines' during the Orchid option fiasco?
Remember that even though the posts are not still available in the archive, there are still copies of certain messages stored on personal hard drives everywhere. Additionally there are lots of people still lurking that remember those days well. So be very careful how you answer.
regards,
frog
gunnabe,
It would definitely be unfair if the board and the company were isolated entities, but they're not.
Frudakis does not hesitate to jump in with both feet when he detects a thread that is a threat to the company and he quickly posts a response.
It is no secret that they monitor the boards. If they are willing to respond when misinterpretations go against the company they have a certain obligation to correct misinterpretations that mislead favorably, as well.
Although it may be a stretch to consider them accompices in the 'groundswell', they can certainly not be considered innocent bystanders either.
regards,
frog
gunnabe,
I included the Orchid option, not necessarily as the agreement itself, but as a groundswell of excitement that was generated based on that option a few years ago.
The scenario played out as the 'countdown' until the option ran out. The play began with published pictures on the boards of Frudakis having dinner with the CEO of Orchid and the reported topic of discussion was DNAP's latest 'discovery' being offered to Orchid to essentially start the clock. Since no deal was struck, the board counted down the 6 month option from that day. Rumors ran rampant about all of the bidders waiting in the wings for Orchid and their option to be out of the way. Reading 'between the lines' such luminaries as w2p and his brother explained how many companies were interested and how soon we would be launching the rocket. Needless to say it was all BS.
You are correct, the details of the option are still in play, but the excitement and promise falsely generated that was based on that agreement, eventually ended, with no further word, only to be replaced by the next round of hype.
The beat goes on.
regards,
frog
Dr. Fru,
After the 1 Billion O/S has been reduced to 100 Million via the speculated 10 to 1 R/S, The difference will be added to the A/S.
3 Billion A/S before the split, divided as 2 Billion A/S and 1 Billion O/S.
3 Billion A/S after the split, divided as 2.9 Billion A/S and 100 Million O/S.
Clear?
I wish you would refrain from your obvious and unsubtle attempts to pump this situation by underestimating and downplaying the effects.
regards,
frog
Dr Fru, You are wrong!
For example if there are 3 billion a/s and only 1 billion o/s, than a, say, 10 for 1 r/s will reduce the o/s to 100 million, but there still remains 2 billion a/s left for issuance...
Under the circumstances you suggest, there will NOT be 2 billion shares left for issuance, there will be 2.9 Billion.
regards,
frog
Blue, Good Call.
In the interest of fairness, I will agree to 'temporarily' remove the Beth Israel deal from that list. I agree that it is premature to include it at this time.
As to finishing what they start, it is not considered finished if it is still in limbo (patents) so the continued refinement of things, while necessary, is still not 'finished'.
Retinome is the specific exception to the trend. It's value has yet to be determined.
I apologize for being unclear and making general statements when I should have obviously been specific, but what I was refering to as unfinished, were the specific topics mentioned previously. GMED deal, Orchid agreement, Malaysian Grant, Asian Collaboration and Biofrontera deal. These efforts have been announced, touted, expanded, speculated upon, and then faded from sight, all without anyone objecting to a fairly obvious trend.
regards,
frog
Teamlasvegas, Fair's Fair.
Tell me why it's relevant, and I'll tell you the answer.
SteveZorbaugh, Thanks for your answers.
For clarification. You say that the reason you are not upset by the lack of completion of projects by the company is your inherent patience. Given that the question concerned such subjects as the GMED and Biofrontera deals, are you still waiting 'patiently' for their completion?
LOL There are many more than 22. Although given your qualification that the data is the result of DNAP analysis, then perhaps the innacuracy is reasonable.
regards,
frog
ice, It sure is!
Teamlasvegas, LOL
Those are the type of responses I always get to such questions.
It amazes me. Although I am unfamiliar with the thought process myself, I think it goes something like this;
'Wow, those questions make me uncomfortable.'
And then, instead of trying to figure out why the questions create a level of unease, the immediate response is;
'Why is this guy asking me uncomfortable questions?'
Apparently pushing the unease away from the question, back at the questioner, allows for a certain relief from the unease but at the detriment of the questioner.
Now back to your question.
If you can establish the relevance of the answer to your question as it relates to the answers to mine, I will be glad to answer it.
regards,
frog
geob, How gracious.
I am no longer willing to butt heads with you...
But I am willing to discuss items .......
Great. Discussion is a two way street. You want me to answer your questions, it is only fair that you answer mine.
I have already answered a number of your questions, so it looks like it's your turn.
People often want to talk about speculative possibilities based on their current enamoration with the latest news, I am curious as to their previous reactions to promises and claims that never materialized.
The history of DNAP includes a long long list of similar bursts of excitement based on reports and PR's that all just faded away. The list includes but is not limited to; The two million dollar GMED deal; The Orchid option (from 4 years ago); The Malaysian Grant; The collaboration with Asian companies (The leaked secret Web Pages were a riot); The Biofrontera Purchase; and last but not least the latest Beth Israel deal.
I am curious to hear from one or more of the faithful longs, how they reacted as every one (so far) of those exciting prospects faded away into obscurity, and how many such 'carrot and stick' episodes they will endure before they get very wary (and weary).
So here are some questions;
- Why is there no apparent unrest among the faithful concerning the consistent failure of the company to finish anything they ever started? (Don't tell me about Ancestry and Witness as they didn't start them.)
- How many times does it take to gain some semblance of caution regarding a new promise? Realize that many of the voices shouting down the voices of caution are the same voices that were 'wetting their pants' over the GMED deal all those years ago.
- How many of the faithful are not so much enamored by the future, as trapped by the past? Bought in on a peak and got caught by a decline, holding on for dear life in the hopes that it's not just a penny stock swindle. Desperately hoping that Frudakis is really a smart guy and not just a charismatic Hummer owner with a good story. Wanting to hear the good news, hoping, but willing to get out tomorrow if they could get their original investment back?
Curious.
regards,
frog
Not if your going to mock me. LOL
But I accept your knowledge to be unquestionable....
Gimme a break!
geob,
Thats what I have that suggests the Beth patents are in "the bag" what have you got that implies differently?
I don't have anything more than a scepticism pounded into me by five years worth of similar happenstance.
In the Biofrontera deal, we had a $200,000.00 up front loan from DNAP, together with a published change to the Biofrontera Board of Directors that included Gabriel and Gomez. Nevertheless that fell through as well. Biofrontera still owes on the loan.
It could well be true that the patents are 'in the bag'. It is possible that no other payments will be required before they are exercisable, we will just have to wait and see.
regards,
frog
geog,
What do you think will happen with those 8 patents from Beth.
It is useless to speculate at this time. The same level of anticipation accompanied the Biofrontera acquisition. Until the R/S has been approved and DNAP actually has funds to begin payments to Beth Israel, there are NO patents.
Also, If you were Tony or Gabe what direction would you persue?
I would have pursued the obvious partnerships with the companies that have the valuable data that DNAP needs for their platform. People seldom realize that the platform requires input in the form of DNA samples from populations sorted by their reactions to drugs. The data is the hard part, the platform can be duplicated in many other ways. DNAP is missing the boat by not trying to partner with the drug company data owners.
And, As an R/D Co. what do think of the advancement's towards incurring distributors for our forensic and ancestry kit's?
DNAP stopped being specifically an R&D company for when they started distributing Ancestry a couple of years ago. The distribution effort has been quite half-hearted since then. It now appears to be gaining some traction.
To close; I am convinced this Co. is not far from their objectives. You tend to recite the past as if you can't look forward. Not trying to be rude just observant.
The facts of the past are all we have to discuss at the present. The future is speculation. Remember it was you who touted the value of history in predicting the future.
regards,
frog
Thank you Blue, Miss Scarlet.
That's very gracious.
best regards,
frog